查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1926909

医疗MIM组件市场按技术、实施类型、最终用户、应用和分销管道划分 - 全球预测（2026-2032年）

Medical MIM Component Market by Technology, Deployment Mode, End User, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医疗 MIM 零件市场价值将达到 41.7 亿美元，到 2026 年将成长至 44.4 亿美元，到 2032 年将达到 64.6 亿美元，年复合成长率为 6.45%。

关键市场统计数据
基准年 2025 41.7亿美元
预计年份：2026年 44.4亿美元
预测年份 2032 64.6亿美元
复合年增长率 (%) 6.45%

本文简要概述了医疗影像组件领域不断发展的格局，并阐述了影响策略决策的临床、技术和采购驱动因素。

由于硬体设计、软体分析和医疗服务模式的同步发展，医学影像组件领域正经历快速演变。本报告首先简要概述当前环境，重点阐述了日益多样化的成像方式、互通性以及不断变化的终端用户需求如何共同重塑采购和临床工作流程。透过向读者提供这一动态背景，我们阐明了对实施和投资决策影响最大的技术和营运因素。

技术突破、软体主导的工作流程和新型商业模式的整合将如何重塑医学影像的临床效用和采购方式

随着影像模式设计、分析技术和部署模式的创新，医学影像领域正经历变革性的转变，重新定义了影像系统在临床实践中的作用。电脑断层扫描（CT）技术的进步，例如多切面和双能量配置，正在拓展诊断能力；而磁振造影（MRI）孔径设计和序列优化的进步则提高了患者的舒适度和检查效率。同时，核医影像技术透过PET和SPECT技术的改进，在分子诊断中发挥越来越重要的作用；超音波也透过向二维、三维/四维和多普勒技术的多元化发展，不断拓展其床边应用。

2025年关税对医疗影像生态系统采购、供应链韧性和临床资产管理的实际影响

2025年公布的关税和贸易政策变化为诊断影像供应链上的相关人员带来了重大的营运和策略考量。儘管关税是财政政策工具，但其影响却波及采购週期、筹资策略和产品定价结构。依赖进口零件和组装诊断影像设备的医院和诊断中心被迫重新评估供应商和维护合同，以降低成本波动并维持服务的连续性。

综合細項分析揭示了模式特征、临床环境和部署偏好如何共同决定采购和部署优先顺序。

要了解市场动态，需要对技术、终端用户环境、应用、部署方法和通路如何相互作用并影响产品的采用和使用有深入的了解。就技术而言，该领域涵盖电脑断层扫描 (CT)，其子类别包括双能量 CT、多切面CT 和单切片电脑断层扫描器。磁振造影(MRI) 涵盖封闭式和开放式系统，而核子医学扫描术诊断则以 PET 和 SPECT 为代表。超音波平台涵盖二维、三维/四维和多普勒功能，X 光解决方案包括电脑放射成像、数位放射线摄影和透视。每种成像方式都有其独特的资本投资、培训和维护方面的考虑因素，这些因素会影响设备的部署地点和方式。

区域趋势和营运需要正在影响全球医疗保健市场的模式采用、服务模式和市场推广客製化。

区域趋势仍然是策略规划的决定性因素，法规结构、报销模式和基础设施成熟度的差异影响着美洲、欧洲、中东和非洲以及亚太地区的采用模式。在美洲，大规模综合医疗系统的存在和强劲的私营部门投资通常会加速先进技术和企业级影像解决方案的采用，而采购流程则侧重于总体拥有成本以及与现有临床IT系统的互通性。

透过整合硬体、软体订阅和卓越服务实现差异化竞争优势，有助于建立长期客户关係并获得持续收入。

市场参与企业不再仅仅依赖硬体效能，而是透过整合产品组合、卓越的售后服务和软体赋能的价值提案来实现差异化竞争。领先的製造商将诊断成像硬体与先进的视觉化套件、基于云端的影像管理和分析订阅服务相结合，以拓展除一次性设备销售之外的收入来源。从遥测预测性维护到快速回应的现场支援协议，服务产品正成为决定客户长期满意度和合约续约率的关键因素。

制定可执行的策略重点，以提高供应链韧性、临床整合和商业性柔软性，从而加速产品推广并维持成长。

为了应对当前复杂的市场环境，产业领导者应优先采取策略行动，提高供应链韧性、临床相关性和商业性柔软性。首先，加强供应链透明度，建立双源采购和近岸外包模式，将有助于降低贸易政策变化带来的风险，并减少前置作业时间波动。投资于组件标准化和模组化系统结构，将有助于实现更灵活的采购，同时支援经济高效的现场升级。

严谨的混合方法整合了关键相关人员的见解、临床文献和营运案例研究，以确保基于证据的分析。

本分析的调查方法结合了定性专家访谈、与关键相关人员的直接对话以及对二级资讯来源的三角验证，从而得出关于当前医疗影像设备组件市场状况的可靠且基于证据的观点。关键资讯来源包括与临床医生、生物医学工程师、采购专业人员和通路负责人的结构化讨论，以深入了解现场营运挑战和不断变化的采购标准。这些对话为不同医疗机构的技术偏好、服务期望和采用障碍提供了背景资讯。

一项统一的策略要务，强调临床协调、服务韧性和数数位化应用是长期成功的决定因素。

结论部分综合分析了从各种技术趋势、市场动态和营运策略中涌现的关键主题。医疗影像设备相关人员必须在一个以特定模式创新、软体和分析功能日益增强以及受贸易政策和区域差异影响的日益复杂的采购环境为特征的环境中运作。成功的关键在于使产品蓝图与临床工作流程保持一致，投资于服务能力以最大限度地减少停机时间，并提供能够满足不同买家需求的灵活商业模式。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 按技术分類的医用MIM组件市场

  • 电脑断层扫描（CT）
    • 双能量CT
    • 多切面CT
    • 单切片电脑断层扫描器
  • 磁振造影
    • 封闭式磁振造影
    • 开放式磁振造影
  • 核子医学扫描术诊断
    • PET
    • SPECT
  • 超音波
    • 二维超音波
    • 3D/4D超音波
    • 多普勒超音波
  • X射线
    • 电脑放射成像
    • 数位放射线摄影
    • 透视

第九章 依部署模式分類的医疗器材MIM部件市场

  • 云
    • 混合云端
    • 私有云端
    • 公共云端
  • 本地部署

第十章 按最终用户分類的医疗器材MIM部件市场

  • 门诊治疗中心
  • 诊断中心
  • 居家医疗
  • 医院
  • 研究所

第十一章 按应用领域分類的医疗器材MIM零件市场

  • 疾病诊断
  • 影像导引治疗
  • 预防性筛检
  • 研究
  • 治疗监测

第十二章 医疗器材MIM部件市场（依分销管道划分）

  • 直销
  • 经销商
    • 电子商务平台
    • OEM分销
    • 第三方经销商
  • 线上销售

第十三章 区域性医疗器材MIM零件市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 医疗器材MIM零件市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国医疗器材MIM零件市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国医疗器材MIM组件市场

第十七章：中国医疗器材MIM零件市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • ACI Alloys, LLC
  • ARC Group Worldwide PLC
  • Dean Group International
  • Form Technologies, Inc.
  • GKN Powder Metallurgy Limited
  • Indo-MIM Private Limited
  • MIM Holding GmbH
  • Nippon Gijutsu Toseki Co., Ltd.
  • PyroGenesis Canada Inc.
  • Seiko Epson Corporation
  • Shanghai Melty MIM Technology Co., Ltd.
  • Sumitomo Electric Industries, Ltd.
Product Code: MRR-4F7A6D4FF371

The Medical MIM Component Market was valued at USD 4.17 billion in 2025 and is projected to grow to USD 4.44 billion in 2026, with a CAGR of 6.45%, reaching USD 6.46 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.17 billion
Estimated Year [2026] USD 4.44 billion
Forecast Year [2032] USD 6.46 billion
CAGR (%) 6.45%

Concise orientation to the evolving medical imaging components landscape that frames clinical, technological, and procurement drivers shaping strategic decisions

The medical imaging component landscape is experiencing rapid evolution driven by parallel advances in hardware design, software analytics, and care delivery models. This report opens with a concise orientation that frames the current environment, highlighting how modality diversification, interoperability priorities, and shifting end-user demands converge to reshape procurement and clinical workflows. By situating the reader within this dynamic context, the introduction clarifies the technological and operational levers that most influence adoption and investment decisions.

Clinicians and health system leaders increasingly evaluate imaging assets not only on image quality and uptime but also on data integration, lifecycle service models, and total cost of ownership. Therefore, introducing the topic with an emphasis on multi-stakeholder value-radiology teams, IT departments, biomedical engineering, and procurement-helps to align subsequent insights to practical decision criteria. The framing also emphasizes the interplay between modality capability and application focus, such as how CT and MRI enhancements affect diagnostic throughput and therapeutic planning.

Finally, the introduction previews methodological rigor and the structure of analysis used throughout the report, reinforcing that conclusions are grounded in an integrative review of clinical literature, regulatory trends, procurement patterns, and supply chain observations. This grounding equips readers with a clear line of sight into what the analysis will and will not address, thereby setting realistic expectations for actionable takeaways.

How converging technological breakthroughs, software-driven workflows, and new commercial models are reshaping clinical utility and procurement approaches in medical imaging

The medical imaging landscape is undergoing transformative shifts as innovation in modality design, analytics, and deployment models redefines what imaging systems can deliver in clinical settings. Advances in computed tomography such as multi-slice and dual-energy architectures are expanding diagnostic capabilities, while magnetic resonance developments in bore design and sequence optimization are improving patient comfort and throughput. Concurrently, nuclear imaging continues to deepen its role in molecular diagnostics with PET and SPECT refinements, and ultrasound diversification across 2D, 3D/4D, and Doppler techniques broadens point-of-care applicability.

At the same time, software-defined imaging and AI-driven analytics are moving from experimental pilots to embedded workflow tools, enabling faster interpretation and decision support. Cloud-enabled deployment and hybrid on-premises arrangements are accelerating data mobility and collaborative diagnostics across hospitals, diagnostic centers, and ambulatory care sites. Distribution channels are also shifting; direct sales relationships coexist with distributor networks that leverage e-commerce platforms and third-party partners to reach diverse end users, including growing homecare use cases.

These shifts are accompanied by service model innovations where vendors bundle equipment with subscription-based software, analytics, and managed services to reduce upfront capital barriers and align incentives toward uptime and clinical performance. Collectively, these developments create a market environment where interoperability, clinical utility, and flexible commercial models increasingly determine long-term adoption.

Practical implications of 2025 tariff actions on procurement, supply chain resilience, and clinical asset management across the medical imaging ecosystem

The introduction of tariffs and trade policy changes announced in 2025 have created a consequential set of operational and strategic considerations for stakeholders across the imaging supply chain. While tariffs are a fiscal policy tool, their practical effects propagate through procurement cycles, sourcing strategies, and product pricing structures. Hospitals and diagnostic centers that rely on imported components or fully assembled imaging systems have had to revisit supplier contracts and maintenance agreements to mitigate cost volatility and preserve service continuity.

In response, procurement teams have accelerated dual-sourcing strategies and regional supplier development to reduce dependency on single origins of supply. Original equipment manufacturers and subsystem suppliers have evaluated localized production, component redesign, and bill-of-material substitutions to manage exposure to tariff bands. At the same time, distributors and channel partners have adapted inventory policies to smooth cost pass-through and maintain competitive bid positioning for end users.

Clinically, payers and health systems have assessed the downstream impact of incremental equipment costs on capital budgeting and upgrade cycles, often prioritizing modular upgrades and software enhancements over full system replacements to sustain diagnostic capabilities. Regulatory and compliance functions have also been engaged to ensure that any supply chain adjustments-such as component substitutions or new manufacturing sites-meet safety and performance standards. Ultimately, the tariff environment has underscored the importance of supply chain visibility, contractual flexibility, and scenario planning for imaging stakeholders.

Integrated segmentation analysis highlighting how modality specifics, care settings, and deployment choices collectively determine procurement and deployment priorities

Understanding market dynamics requires a nuanced view of how technology, end-user settings, applications, deployment choices, and distribution pathways interact to shape adoption and use. By technology, the landscape encompasses computed tomography, with subcategories including dual-energy CT, multi-slice CT, and single-slice CT; magnetic resonance imaging, spanning closed bore and open bore systems; nuclear imaging, represented by PET and SPECT modalities; ultrasound platforms covering 2D, 3D/4D, and Doppler capabilities; and X-ray solutions that include computed radiography, digital radiography, and fluoroscopy. Each modality segment presents distinct capital, training, and maintenance considerations that influence where and how devices are deployed.

Examining end users reveals divergent needs across ambulatory care centers, diagnostic centers, homecare, hospitals, and research institutes. Hospitals typically demand high-throughput, enterprise-grade systems that integrate with electronic health records and PACS, whereas ambulatory and homecare settings prioritize compact form factors, ease of use, and rapid serviceability. Application-focused segmentation shows that disease diagnosis, image-guided interventions, preventive screening, research, and therapeutic monitoring each drive different modality preferences and accessory ecosystems, shaping purchase criteria and aftermarket service requirements.

Deployment mode considerations-cloud versus on-premises, including hybrid, private, and public cloud models-affect data governance, interoperability, and remote collaboration. Distribution channels vary from direct sales to distributors and online sales; within distributor networks, differences emerge between e-commerce platforms, OEM distribution, and third-party distributors. These interlocking dimensions guide competitive positioning, product roadmaps, and commercialization strategies.

Regional dynamics and operational imperatives that determine modality adoption, service models, and go-to-market customization across global healthcare markets

Regional dynamics continue to be a decisive factor in strategic planning, with variations in regulatory frameworks, reimbursement models, and infrastructure maturity shaping adoption patterns across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, the presence of large integrated health systems and strong private-sector investment typically accelerates uptake of advanced modalities and enterprise imaging solutions, while procurement processes emphasize total cost of ownership and interoperability with established clinical IT systems.

Across Europe, Middle East & Africa, heterogeneous regulatory landscapes and mixed public-private funding models require vendors to adopt flexible commercial strategies and localized service footprints. Governments and large provider networks in certain countries prioritize preventive screening programs and population health integration, which can create demand for portable imaging and cloud-enabled analytics. In the Asia-Pacific region, rapid infrastructure expansion, growing diagnostic volumes, and increasing investment in research institutions drive diverse opportunities for both high-end modalities and scalable ultrasound and X-ray solutions tailored for high-throughput environments.

Transitioning across regions often necessitates adapting product specifications, training programs, and financing arrangements to meet local clinical protocols and budgetary constraints. Therefore, regional go-to-market strategies must balance global platform standardization with localized customization to optimize both clinical adoption and operational sustainability.

Competitive differentiation through integrated hardware, software subscriptions, and service excellence that sustain long-term customer relationships and recurring revenue

Market participants are differentiating on the basis of integrated portfolios, aftermarket service excellence, and software-enabled value propositions rather than purely on hardware capabilities. Leading manufacturers increasingly pair imaging hardware with advanced visualization suites, cloud-based image management, and analytics subscriptions to extend revenue streams beyond one-time equipment sales. Service offerings-ranging from predictive maintenance enabled by telemetry to rapid field support contracts-have become critical determinants of long-term customer satisfaction and renewal rates.

Channel partners and distributors are investing in digital commerce and logistics capabilities to shorten lead times and improve transparency around spare parts and consumables. Strategic partnerships between hardware vendors, independent software developers, and healthcare IT firms are also producing interoperable ecosystems that facilitate seamless data flow into enterprise clinical workflows. Research institutions and specialized clinical centers are driving early adoption of novel imaging protocols and adjunct software, which helps to validate clinical utility and accelerate broader commercialization.

In procurement interactions, buyers increasingly evaluate vendor stability, roadmap clarity, and the ability to support lifecycle upgrades. Firms that demonstrate strong compliance track records, robust quality systems, and scalable global service networks are positioned to capture long-term relationships with large health systems, diagnostic chains, and research consortia. Overall, sustainable competitive advantage is migrating toward combined strengths in clinical validation, service delivery, and digital enablement.

Actionable strategic priorities that enhance supply resilience, clinical integration, and commercial flexibility to accelerate adoption and sustain growth

Industry leaders should prioritize strategic actions that enhance supply resilience, clinical relevance, and commercial flexibility to navigate current market complexities. First, strengthening supply chain transparency and establishing dual-sourcing or nearshoring options will mitigate exposure to trade policy shifts and reduce lead-time volatility. Investing in component standardization and modular system architectures enables more agile sourcing while supporting cost-effective field upgrades.

Second, accelerating integration of analytics and workflow automation into imaging platforms can materially improve clinical throughput and decision support, which in turn strengthens the value proposition for buyers. Vendors should invest in validated AI tools, clear performance metrics, and clinician-focused user experience design to drive adoption. Third, evolving commercial models toward outcome-linked and subscription-based structures can lower entry barriers for providers while creating predictable recurring revenue streams for suppliers.

Fourth, regional go-to-market strategies must combine global product consistency with localized service, training, and financing solutions to match differing procurement cycles and regulatory requirements. Finally, organizations should expand cross-sector partnerships-linking vendors, payers, and research institutions-to co-develop evidence that demonstrates clinical and economic value, thereby accelerating reimbursement pathways and clinical integration.

Rigorous mixed-methods approach combining primary stakeholder insights, clinical literature, and operational case studies to ensure evidence-based analysis

The research methodology underpinning this analysis combines qualitative expert interviews, primary stakeholder engagements, and secondary source triangulation to produce a robust, evidence-informed view of the medical imaging components landscape. Primary inputs included structured discussions with clinicians, biomedical engineers, procurement officers, and channel partners to capture firsthand operational challenges and evolving procurement criteria. These engagements provided context on technology preferences, service expectations, and adoption barriers across different care settings.

Secondary research encompassed peer-reviewed clinical literature, regulatory guidance, and publicly available industry documentation to validate technical performance characteristics and compliance trends. Market intelligence was cross-referenced with case studies on deployment outcomes and supply chain adjustments, ensuring that observations reflect real-world implementations rather than theoretical possibilities. The analysis emphasized transparency in assumptions and differentiated between observed trends and projected scenarios.

Finally, synthesis involved iterative validation with domain experts to refine interpretations and ensure that conclusions accurately represent prevailing clinical, operational, and commercial realities. This mixed-methods approach supports a balanced representation of technical detail and strategic relevance for decision-makers.

Synthesis of strategic imperatives emphasizing clinical alignment, service resilience, and digital enablement as determinants of long-term success

The conclusion synthesizes the key themes that emerged across technology, market dynamics, and operational strategy. Medical imaging component stakeholders must navigate a landscape characterized by modality-specific innovation, the expanding role of software and analytics, and an increasingly complex procurement environment influenced by trade policy and regional variability. Success hinges on aligning product roadmaps with clinical workflows, investing in service capabilities that minimize downtime, and offering flexible commercial models that address diverse buyer constraints.

Moreover, resilience in supply chains and clarity around regulatory compliance will continue to be decisive factors as geopolitical and economic policy shifts create episodic disruption. Vendors that successfully integrate digital capabilities, demonstrate clinical value through evidence generation, and cultivate localized service networks will be best positioned to capture sustained adoption across hospitals, diagnostic centers, ambulatory settings, and research institutions.

In sum, the sector is moving toward solutions that deliver not only image fidelity but also actionable data, reliable service, and commercial models that reduce barriers to procurement. Stakeholders who proactively adapt across these dimensions will secure strategic advantage in a rapidly evolving healthcare landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical MIM Component Market, by Technology

  • 8.1. Computed Tomography
    • 8.1.1. Dual-Energy Ct
    • 8.1.2. Multi-Slice Ct
    • 8.1.3. Single-Slice Ct
  • 8.2. Magnetic Resonance Imaging
    • 8.2.1. Closed Bore Mri
    • 8.2.2. Open Bore Mri
  • 8.3. Nuclear Imaging
    • 8.3.1. Pet
    • 8.3.2. Spect
  • 8.4. Ultrasound
    • 8.4.1. 2D Ultrasound
    • 8.4.2. 3D/4D Ultrasound
    • 8.4.3. Doppler Ultrasound
  • 8.5. X-Ray
    • 8.5.1. Computed Radiography
    • 8.5.2. Digital Radiography
    • 8.5.3. Fluoroscopy

9. Medical MIM Component Market, by Deployment Mode

  • 9.1. Cloud
    • 9.1.1. Hybrid Cloud
    • 9.1.2. Private Cloud
    • 9.1.3. Public Cloud
  • 9.2. On-Premises

10. Medical MIM Component Market, by End User

  • 10.1. Ambulatory Care Centers
  • 10.2. Diagnostic Centers
  • 10.3. Homecare
  • 10.4. Hospitals
  • 10.5. Research Institutes

11. Medical MIM Component Market, by Application

  • 11.1. Disease Diagnosis
  • 11.2. Image-Guided Interventions
  • 11.3. Preventive Screening
  • 11.4. Research
  • 11.5. Therapeutic Monitoring

12. Medical MIM Component Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
    • 12.2.1. E-Commerce Platforms
    • 12.2.2. Oem Distribution
    • 12.2.3. Third-Party Distributors
  • 12.3. Online Sales

13. Medical MIM Component Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical MIM Component Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical MIM Component Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Medical MIM Component Market

17. China Medical MIM Component Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ACI Alloys, LLC
  • 18.6. ARC Group Worldwide PLC
  • 18.7. Dean Group International
  • 18.8. Form Technologies, Inc.
  • 18.9. GKN Powder Metallurgy Limited
  • 18.10. Indo-MIM Private Limited
  • 18.11. MIM Holding GmbH
  • 18.12. Nippon Gijutsu Toseki Co., Ltd.
  • 18.13. PyroGenesis Canada Inc.
  • 18.14. Seiko Epson Corporation
  • 18.15. Shanghai Melty MIM Technology Co., Ltd.
  • 18.16. Sumitomo Electric Industries, Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL MIM COMPONENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL MIM COMPONENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MEDICAL MIM COMPONENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DUAL-ENERGY CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DUAL-ENERGY CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DUAL-ENERGY CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY MULTI-SLICE CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY MULTI-SLICE CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY MULTI-SLICE CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY SINGLE-SLICE CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY SINGLE-SLICE CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY SINGLE-SLICE CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY CLOSED BORE MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY CLOSED BORE MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY CLOSED BORE MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY OPEN BORE MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY OPEN BORE MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY OPEN BORE MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY SPECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY SPECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY SPECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY 2D ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY 2D ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY 2D ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY 3D/4D ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY 3D/4D ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY 3D/4D ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DOPPLER ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DOPPLER ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DOPPLER ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY FLUOROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY FLUOROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY FLUOROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY HYBRID CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY HYBRID CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PRIVATE CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PRIVATE CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PUBLIC CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PUBLIC CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY ON-PREMISES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY ON-PREMISES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DISEASE DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DISEASE DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY IMAGE-GUIDED INTERVENTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY IMAGE-GUIDED INTERVENTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY IMAGE-GUIDED INTERVENTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PREVENTIVE SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PREVENTIVE SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY PREVENTIVE SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY THERAPEUTIC MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY THERAPEUTIC MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY OEM DISTRIBUTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY OEM DISTRIBUTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY OEM DISTRIBUTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 250. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 252. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 253. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 254. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 255. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 256. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 257. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 258. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 259. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. GCC MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 289. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 290. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 291. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 292. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 293. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 294. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 295. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 296. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 297. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 298. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 300. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 301. G7 MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 302. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 303. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 304. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 305. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 306. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 307. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 308. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 309. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 310. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 311. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 312. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 313. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 314. NATO MEDICAL MIM COMPONENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 315. GLOBAL MEDICAL MIM COMPONENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, BY NUCLEAR IMAGING, 2018-2032 (USD MILLION)
  • TABLE 321. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, BY X-RAY, 2018-2032 (USD MILLION)
  • TABLE 323. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 324. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 325. UNITED STATES MEDICAL MIM COMPONENT MARKET SIZE, BY END USER, 2018-2032 (USD MILL